The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Molecular Biosciences
(Jul 2022)
Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis
Guido Veit,
Iris Silva,
Massimo Conese,
Onofrio Laselva
Affiliations
Guido Veit
Department of Physiology, McGill University, Montréal, QC, Canada
Iris Silva
S2AQUAcoLAB, Olhao, Portugal
Massimo Conese
Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
Onofrio Laselva
Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
DOI
https://doi.org/10.3389/fmolb.2022.975946
Journal volume & issue
Vol. 9
Abstract
Read online
No abstracts available.
Keywords
CFTR
cystic fibrosis
CFTR corrector
SLC6A14
IGFBP-6
WeChat QR code
Close